Laura R. Barkley

678 total citations
16 papers, 505 citations indexed

About

Laura R. Barkley is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Laura R. Barkley has authored 16 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Laura R. Barkley's work include DNA Repair Mechanisms (7 papers), Global Cancer Incidence and Screening (3 papers) and Microtubule and mitosis dynamics (3 papers). Laura R. Barkley is often cited by papers focused on DNA Repair Mechanisms (7 papers), Global Cancer Incidence and Screening (3 papers) and Microtubule and mitosis dynamics (3 papers). Laura R. Barkley collaborates with scholars based in United States, Ireland and Japan. Laura R. Barkley's co-authors include Cyrus Vaziri, Damien Slater, Xiaohui Bi, Satoshi Tateishi, Haruo Ohmori, Masaru Yamaizumi, Tovah A. Day, Corrado Santocanale, Ying Zou and Heinz‐Peter Nasheuer and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Cell Biology.

In The Last Decade

Laura R. Barkley

16 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura R. Barkley United States 12 405 206 159 95 31 16 505
Eun‐Kyoung Breuer United States 13 309 0.8× 152 0.7× 181 1.1× 66 0.7× 41 1.3× 17 475
Yun Seong Jeong United States 9 397 1.0× 143 0.7× 147 0.9× 44 0.5× 24 0.8× 17 499
Warapen Treekitkarnmongkol United States 8 281 0.7× 87 0.4× 182 1.1× 107 1.1× 19 0.6× 14 410
Ernest Medina United States 6 444 1.1× 80 0.4× 160 1.0× 101 1.1× 45 1.5× 9 607
Andressa Gois Morales Brazil 11 250 0.6× 133 0.6× 70 0.4× 79 0.8× 15 0.5× 13 353
Guoyang He China 14 448 1.1× 341 1.7× 101 0.6× 38 0.4× 37 1.2× 24 579
Isabel Soria‐Bretones Canada 9 293 0.7× 84 0.4× 126 0.8× 57 0.6× 22 0.7× 10 378
Silvia Licciulli Italy 8 366 0.9× 83 0.4× 127 0.8× 59 0.6× 60 1.9× 8 470
Zhen Ning Wee Singapore 4 267 0.7× 113 0.5× 111 0.7× 71 0.7× 24 0.8× 4 385
Marlese A. Pisegna United States 6 326 0.8× 112 0.5× 103 0.6× 101 1.1× 22 0.7× 7 426

Countries citing papers authored by Laura R. Barkley

Since Specialization
Citations

This map shows the geographic impact of Laura R. Barkley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura R. Barkley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura R. Barkley more than expected).

Fields of papers citing papers by Laura R. Barkley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura R. Barkley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura R. Barkley. The network helps show where Laura R. Barkley may publish in the future.

Co-authorship network of co-authors of Laura R. Barkley

This figure shows the co-authorship network connecting the top 25 collaborators of Laura R. Barkley. A scholar is included among the top collaborators of Laura R. Barkley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura R. Barkley. Laura R. Barkley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Li, Rui, Xiao Hu, Ning Ge, Michael J. Kerin, & Laura R. Barkley. (2025). Abstract 3142: Patient-derived models of breast cancer for drug screening and precision medicine approaches. Cancer Research. 85(8_Supplement_1). 3142–3142. 1 indexed citations
3.
Watson, Luke, Laura Deedigan, Róisín M. Dwyer, et al.. (2020). Targeting stromal cell Syndecan‐2 reduces breast tumour growth, metastasis and limits immune evasion. International Journal of Cancer. 148(5). 1245–1259. 22 indexed citations
4.
Barkley, Laura R., et al.. (2015). Mobile Mammography, Race, and Insurance: Use Trends Over a Decade at a Comprehensive Urban Cancer Center. Journal of Oncology Practice. 11(1). e75–e80. 13 indexed citations
5.
Elliman, Stephen J., et al.. (2014). Selective repression of the oncogene cyclin D1 by the tumor suppressor miR-206 in cancers. Oncogenesis. 3(8). e113–e113. 48 indexed citations
6.
Riley, Elizabeth C., et al.. (2014). Impact of location to repeat mobile mammography utilization trends: 10-year analysis of a comprehensive urban cancer center.. Journal of Clinical Oncology. 32(15_suppl). 6577–6577. 1 indexed citations
7.
Riley, Elizabeth C., et al.. (2014). Uninsured utilization of the mobile mammography: 10-year analysis.. Journal of Clinical Oncology. 32(26_suppl). 12–12. 2 indexed citations
8.
Barkley, Laura R. & Corrado Santocanale. (2013). MicroRNA-29a regulates the benzo[a]pyrene dihydrodiol epoxide-induced DNA damage response through Cdc7 kinase in lung cancer cells. Oncogenesis. 2(7). e57–e57. 32 indexed citations
9.
Barkley, Laura R., Komaraiah Palle, Michael Durando, et al.. (2012). c-Jun N-terminal kinase–mediated Rad18 phosphorylation facilitates Polη recruitment to stalled replication forks. Molecular Biology of the Cell. 23(10). 1943–1954. 18 indexed citations
10.
Day, Tovah A., Laura R. Barkley, Naoko Kakusho, et al.. (2010). Phosphorylated Rad18 directs DNA Polymerase η to sites of stalled replication. The Journal of Cell Biology. 191(5). 953–966. 60 indexed citations
11.
Barkley, Laura R., et al.. (2009). Reduced expression of GINS complex members induces hallmarks of pre-malignancy in primary untransformed human cells. Cell Cycle. 8(10). 1577–1588. 19 indexed citations
12.
Barkley, Laura R., et al.. (2007). Cdc6 is a rate-limiting factor for proliferative capacity during HL60 cell differentiation. Experimental Cell Research. 313(17). 3789–3799. 15 indexed citations
13.
Barkley, Laura R., Haruo Ohmori, & Cyrus Vaziri. (2007). Integrating S-phase checkpoint signaling with trans-lesion synthesis of bulky DNA adducts. Cell Biochemistry and Biophysics. 47(3). 392–408. 15 indexed citations
14.
Liu, Peijun, Laura R. Barkley, Tovah A. Day, et al.. (2006). The Chk1-mediated S-phase Checkpoint Targets Initiation Factor Cdc45 via a Cdc25A/Cdk2-independent Mechanism. Journal of Biological Chemistry. 281(41). 30631–30644. 80 indexed citations
15.
Bi, Xiaohui, Laura R. Barkley, Damien Slater, et al.. (2006). Rad18 Regulates DNA Polymerase κ and Is Required for Recovery from S-Phase Checkpoint-Mediated Arrest. Molecular and Cellular Biology. 26(9). 3527–3540. 142 indexed citations
16.
Thornton, Mark, Laura R. Barkley, Justin C. Mason, & Sunil Shaunak. (1999). Anti-Kaposi’s Sarcoma and Antiangiogenic Activities of Sulfated Dextrins. Antimicrobial Agents and Chemotherapy. 43(10). 2528–2533. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026